In 2022, TECHLAB was acquired by SSI Diagnostica Group. Today, TECHLAB functions as a brand under SSI Diagnostica Group.
About SSI Diagnostica Group: SSI Diagnostica Group is a global in vitro diagnostics (IVD) company, specializing in infectious disease diagnostics. We employ staff and operate offices in Denmark, the United States, and China, with a total of eleven sites across three different continents. Each year, we deliver diagnostic solutions in more than 130 countries and manufacture more than 60 million diagnostic tests – helping people receive the right diagnosis and, ultimately, the right treatment as quickly as possible. Operating as one company today, SSI Diagnostica Group is historically the result of a series of acquisitions: SSI Diagnostica (2016), CTK Biotech (2020), Beijing Genesee Biotech (2020), Techlab (2022), Gulf Coast Scientific (2025), and InDevR (2026). Each brand has brought unique expertise and experience to the group, and as a combined company we offer more than 200 years of combined scientific expertise. SSID Group’s mission is to empower healthcare professionals to prevent, monitor, and diagnose infectious diseases – enabling better treatment outcomes for patients worldwide. SSI Diagnostica group has four disease focus areas: Gastric, Respiratory, Bloodborne, and general microbiology.
Qualisys is a leading provider of motion capture technology and has a long history of supplying our customers with high-end camera systems and expertise in capturing and analyzing movements. Our customers are found within Life Sciences, Engineering and Entertainment. The technology is used both in Research and Clinical use, Virtual Reality (VR), and Animation.
Qualisys offers a wide range of products and services and has offices in Gothenburg, Chicago and Shanghai.
Working at Qualisys
At Qualisys we develop world-leading motion capture technology. We have a small and dynamic development process where we put the individual in the center. We try to work as agile as possible and follow the Scrum mindset where it is possible. We have divided the work into specialized teams that work closely together and plan their job by themselves.
At Mirah, we’re revolutionizing the way primary care supports patients with behavioral health challenges by bringing the Collaborative Care Model (CoCM) to life through our transformative Collaborative Care Practice Optimization Solution.
Our innovative tools go beyond traditional systems, empowering organizations to achieve life-changing clinical outcomes while attaining program sustainability and driving organizational economics. With a best-in-class assessment engine for tracking patient progress, our fully integrated solution delivers actionable insights, powerful analytics, and unmatched precision to support measurement-based care and collaborative care at scale.
We pair enterprise-level technology with expert clinical support to ensure the effective, sustainable and scalable implementation of collaborative care programs.
To learn more, visit mirah.com.